A Case of Acute Kidney Injury During Eltrombopag Use Successfully Treated With Plasma Exchange in Addition to Antithrombotic Therapy

Eltrombopag (EPAG), a thrombopoietin receptor agonist, has emerged as a valuable option for the treatment of immune thrombocytopenic purpura. However, its use has raised concerns regarding thrombotic complications. Herein, we present a case involving a 60-year-old woman with immune thrombocytopenic...

Full description

Saved in:
Bibliographic Details
Main Authors: Noriko Ueno, Yasuo Kusunoki, Toru Kida, Shun Oda, Akane Yamano, Fumi Nakayama, Shungo Fukuda, Natsuko Ikeda, Tomoko Namba-Hamano, Masato Homma, Masanobu Takeji
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Kidney Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059525000433
Tags: Add Tag
No Tags, Be the first to tag this record!